MSH2 and cancer: The specific cancer phenotype has been reported to be gene dependant: MLH1- and MSH2-associated CMMRD were associated with a higher hematological malignancies rate and earlier diagnosed, compared with PMS2-associated CMMRD where brain tumors were more frequent [18].